文献速递新发突发、热带与寄生虫病

工程化NS1用于寨卡病毒血清学诊断的敏感性与特异性验证

Engineered NS1 for Sensitive, Specific Zika Virus Diagnosis from Patient Serology.
PubMed 文献 · Emerg Infect Dis · 2021-01-01

研究利用盲法患者血浆验证基于工程化寨卡病毒NS1抗原的ELISA和快速免疫层析试验,并开发了特异性单克隆抗体。血清学试验在恢复期血浆中敏感性为71%至88%,急性期敏感性较低,但NS1抗体可补充提升早期感染检出。

要点

  • 工程化寨卡NS1抗原可降低与登革病毒的交叉反应。
  • 血清学试验对恢复期血浆敏感性为71%–88%。
  • NS1抗体可补充血清学试验提高早期感染检出。

核心结论

  • 基于工程化寨卡NS1的血清学检测对恢复期血浆敏感,且NS1抗体可提升早期感染检出。

研究设计与样本

  • 使用特征明确的寨卡和登革患者血浆以盲法验证ELISA和快速免疫层析试验。

主要发现

  • 血清学试验对恢复期血浆的敏感性范围为71%至88%,取决于IgM/IgG/NS1各试验表现。
  • 急性期血浆的血清学试验敏感性普遍较低。
  • 寨卡NS1抗体可补充血清学试验以提高早期感染检出敏感性。

关键数值与推荐

  • 恢复期血浆敏感性为71%–88%,具体取决于单项试验(IgM/IgG/NS1)的表现。

临床怎么用

  • 采用工程化寨卡NS1抗原的血清学检测有助于区分寨卡与登革感染。
  • NS1抗体可辅助提升早期寨卡感染的血清学检出。

局限性

  • 血清学试验在急性期血浆中敏感性较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dengue virus (DENV) and Zika virus (ZIKV) belong to the Flaviviridae family of viruses spread by Aedes aegypti mosquitoes in tropical and subtropical areas. Accurate diagnostic tests to differentiate the 2 infections are necessary for patient management and disease control. Using characterized ZIKV and DENV patient plasma in a blind manner, we validated an ELISA and a rapid immunochromatographic test for ZIKV detection. We engineered the ZIKV nonstructural protein 1 (NS1) for sensitive serologic detection with low cross reactivity against dengue and developed monoclonal antibodies specific for the ZIKV NS1 antigen. As expected, the serologic assays performed better with convalescent than acute plasma samples; the sensitivity ranged from 71% to 88%, depending on the performance of individual tests (IgM/IgG/NS1). Although serologic tests were generally less sensitive with acute samples, our ZIKV NS1 antibodies were able to complement the serologic tests to achieve greater sensitivity for detecting early infections.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Yap TL, Hong SY, Soh JH, et al. Engineered NS1 for Sensitive, Specific Zika Virus Diagnosis from Patient Serology. Emerg Infect Dis. 2021. PMID: 33900180. doi:10.3201/eid2705.190121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。